Trial intelligence / Profile preview

AGEING: Envarsus in Elderly Kidney Transplant

NCT03005236Phase 4Unknown

Sponsor
University Hospitals Birmingham
Start
Apr 2017
Primary completion
Apr 2019
Modality
RNA-Targeting Small Molecules
01

Overview

A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by University Hospitals Birmingham. Status: unknown.

02

Drugs

tacrolimus
03

Conditions

kidney transplant rejection

Beyond the preview

Go deeper on NCT03005236.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03005236.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call